SCHEMBL7356574

SCHEMBL7356574

[CH]1CN(c2ncccn2)CCN1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.57
KDM4E B2RXH2 3/20 0.57
CYP2D6 P10635 3/20 0.44
CYP3A4 P08684 2/20 0.44
TSHR P16473 2/20 0.44
HSD17B10 Q99714 3/20 0.42
HPGD P15428 1/20 0.42
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
CYP1A2 P05177 2/20 0.40
POLB P06746 2/20 0.39
PLD1 Q13393 1/20 0.39
USP2 O75604 1/20 0.39
GAA P10253 1/20 0.37
HTT P42858 1/20 0.37
CYP2C19 P33261 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7775378 0.79 ALDH1A1 (0.35) ALDH1A1KDM4ECYP3A4TSHRHSD17B10
SCHEMBL5497754 0.79 ALDH1A1 (0.45) ALDH1A1KDM4ECYP2D6CYP3A4TSHR
SCHEMBL27545674 0.78 PLD1 (0.64) ALDH1A1KDM4ECYP2D6CYP3A4TSHR
2-Piperazin-1-Yl-Pyrimidine SCHEMBL893739 0.74 ALDH1A1 (0.95) ALDH1A1KDM4ECYP2D6CYP3A4TSHR
2-Piperazin-1-Yl-Pyrimidine SCHEMBL169214 0.74 ALDH1A1 (0.95) ALDH1A1KDM4ECYP2D6CYP3A4TSHR
2-Piperazin-1-Yl-Pyrimidine SCHEMBL101561 0.72 ALDH1A1 (1.00) ALDH1A1KDM4ECYP2D6CYP3A4TSHR
2-Piperazin-1-Yl-Pyrimidine SCHEMBL924147 0.72 ALDH1A1 (1.00) ALDH1A1KDM4ECYP2D6CYP3A4TSHR
2-Piperazin-1-Yl-Pyrimidine SCHEMBL27324991 0.72 ALDH1A1 (0.91) ALDH1A1KDM4ECYP2D6CYP3A4TSHR
2-Piperazin-1-Yl-Pyrimidine SCHEMBL5375472 0.72 ALDH1A1 (0.91) ALDH1A1KDM4ECYP2D6CYP3A4TSHR
2-Piperazin-1-Yl-Pyrimidine SCHEMBL27920766 0.72 ALDH1A1 (0.91) ALDH1A1KDM4ECYP2D6CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1082308-A1 HETEROCYCLICALLY SUBSTITUTED AMIDES USED AS CALPAIN INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 2001-03-14 EP disclosed
EP-0991642-A1 2-AMINOALKYLAMINOQUINOLINES AS DOPAMINE D4 LIGANDS NEUROGEN CORPORATION (US) 2000-04-12 EP disclosed
WO-1999054305-A1 HETEROCYCLICALLY SUBSTITUTED AMIDES USED AS CALPAIN INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 1999-10-28 WO disclosed
WO-1998056786-A1 2-AMINOALKYLAMINOQUINOLINES AS DOPAMINE D4 LIGANDS NEUROGEN CORPORATION (US) 1998-12-17 WO disclosed